Answers are grounded in this paper and cite their sources.
Traumatic brain injury (TBI) ranks among the top causes of illness and death on a global scale, characterized by a range of complex and diverse pathophysiological processes that include mechanical disruption, excitotoxicity, oxidative stress, and neuroinflammation. At the molecular level, TBI triggers primary and secondary injury mechanisms that affect neuronal survival, synaptic integrity, and long-term neurological outcomes. The endocannabinoid system (ECS), a lipid-based neuromodulatory framework, is a vital regulator of neural homeostasis, synaptic plasticity, and immune responses. This brief review integrates molecular and mechanistic insights into TBI, positioning the ECS as an injury-responsive modulator of neuroinflammation and neurodegeneration. Collectively, these insights position the ECS as a context-dependent modulatory system with therapeutic relevance in TBI.
No takes yet. Share an insight, caveat, or question.
Hilal Kalkan (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: